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Abstract.  Monoclonal antibodies were made against a 
truncated form of human laminin isolated from 
placenta.  12 antibodies were isolated and character- 
ized.  All antibodies stained basement membranes in 
placenta and immunoprecipitated laminin  from media 
of cultured choriocarcinoma cells. Three antibodies, 
3E5, 4C7,  and 4El0, partially blocked the neurite- 
promoting activity of laminin.  Addition of a  second 
antibody, goat anti-mouse IgG, caused more complete 
blocking of the activity. Two of the blocking antibod- 
ies, 4C7 and 4El0, reacted with epitopes within the 
globular domain at the end of the long arm of lami- 
nin,  and the third one,  3E5,  reacted at the end of the 
rod-like portion of the long arm adjacent to the globu- 
lar domain,  as shown by electron microscopy after ro- 
tary shadowing.  Five nonblocking antibodies used in 
the same test reacted with epitopes in other domains 
of the molecule.  Blocking antibodies 3E5 and 4El0 
could be used in immunoblotting and both antibodies 
reacted with the same polypeptides in pepsin frag- 
ments of human laminin,  the predominant polypep- 
tides being ~400 kD.  When a crude extract of human 
amnion was used as a  source of intact laminin,  the 
4El0 antibody detected a  single polypeptide of *400 
kD. A  nonblocking antibody, 2E8,  which reacted at 
the center of the laminin cross, reacted predominantly 
with a 200-kD polypeptide in human laminin  frag- 
ments and exclusively with a 200-kD polypeptide 
in amnion extract and in rat laminin.  Our results 
with human laminin  match the results by Edgar,  D., 
R. Timpl,  and H. Thoenen,  1984,  EMBO (Eur. Mol. 
Biol.  Organ.) J., 3:1463-1468,  in which the neurite- 
promoting activity of mouse laminin  resides at the end 
of the long arm,  which is also the site for heparin 
binding.  However, since the active fragments of human 
laminin did not bind to heparin,  the neurite-promoting 
site should be different from the heparin-binding  site. 
Our results further suggest that the neurite-promoting 
site may be contained in or close to the 400-kD com- 
ponent of laminin. 
E 
Ir~IN is a large glycoprotein present in all basement 
membranes (Chung  et al.,  1977; Timpl et al.,  1979; 
Hogan, 1980; Sakashita and Ruoslahti,  1980). It has 
a molecular mass of '~900 kD and is composed of disul- 
fide-cross-linked polypeptides with Mrs of "o200 and 400 
kD, as determined by SDS PAGE. In electron microscopy af- 
ter rotary shadowing,  purified  laminin  has the shape  of a 
cross with one long and three short arms (Engel et al., 1981). 
The long arm ends with one large globule and the short arms 
each end with two smaller globules. 
Numerous biological activities have been assigned to lami- 
nin (Timpl et al., 1983; Kleinman et al., 1985; vonder Mark 
and Kuhl,  1985). Laminin  has been reported to affect cell 
adhesion and migration  (Terranova et al.,  1980; Carlsson et 
al.,  1981; Johansson et al.,  1981; Darmon,  1982; Terranova 
et al., 1982; McCarthy et al., 1983; Couchman et al., 1983; 
Bronner-Fraser,  1984; Goodman and Newgreen,  1985) and 
growth and differentiation of nucleated cells in vitro (Rizzino 
et al.,  1980; Grover et al.,  1983), to promote adhesion  of 
platelets  (Ill et al.,  1984), and to bind to collagen (Woodley 
et al.,  1983; Kleinman  et al.,  1983; Charonis  et al.,  1985), 
heparin,  and  other glycosaminoglycans  (Sakashita  et al., 
1980; Del Rosso et al.,  1981), lectins (Shibata et al.,  1982), 
plasminogen  and  its  tissue-type activator  (Salonen  et al., 
1984), sulfated  glycolipids  (Roberts  et al.,  1985), bacteria 
(Switalski  et al.,  1984; Speziale et al.,  1982; Lopes et al., 
1985), and the complement components Clq (Bohnsack  et 
al., 1985) and C3 (Leivo and Engvall,  1986). Some of these 
activities have been assigned to different molecular domains 
of laminin.  Thus, the end of the long arm of laminin  may 
bind to heparin (Ott et al., 1982), type IV collagen (Charonis 
et al., 1985), and other laminin molecules (Yurchenco et al., 
1985), and the ends of the short arms may bind to type IV 
collagen (Charonis et al., 1985), the collagenous domains of 
Clq (Bohnsack et al., 1985), and to other laminin molecules 
(Yurchenco  et al.,  1985). 
Perhaps the most potent activity of laminin  described so 
far is its capacity to induce and promote neurite  outgrowth 
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vous  systems  (Baron-Van  Evercooren et  al.,  1982;  Man- 
thorpe et al.,  1983; Rogers et al.,  1983; Wewer et al.,  1983; 
Edgar et al.,  1984;  Smalheiser et al.,  1984;  Adler et al., 
1985).  Other  extracellular  matrix  components,  including 
fibronectin and different types of collagens, may also show 
neurite-promoting activity (Akers et al.,  1981; Vlodavsky et 
al., 1982; Rogers et al., 1983; Manthorpe et al., 1983; Adler 
et al.,  1985),  but their specific neurite-promoting activities 
vary with different cell types and tend to be lower than that 
of laminin (Davis et al.,  1985b). 
Further evidence for the high neurite-promoting potency 
of laminin comes from experiments in which factors capable 
of promoting neurite outgrowth from cultured neurons have 
been demonstrated in and purified from conditioned media 
from different cell types (Davis et al.,  1985a; Lander et al., 
1985). These purified factors have subsequently been shown 
to contain laminin, often in complex with proteoglycans, but 
not to contain fibronectin or collagen. It seems likely that 
laminin is the active species in these factors. 
Relationships between structure and function of laminin 
are incompletely known. In our hands it has been difficult 
to prepare defined domains of laminin by proteolytic diges- 
tion for structural and functional studies.  Furthermore, at 
least the neurite-promoting activity of laminin is dependent 
on an intact secondary or tertiary structure of laminin at the 
site that interacts with neurons. Conformational changes in 
laminin induced by urea or low pH lead to loss of neurite- 
promoting activity (our unpublished observation). We there- 
fore decided to prepare monoclonal antibodies against lami- 
nin and to use these to probe for structure and function. In 
this report we describe the production and characterization 
of such antibodies and the use of these antibodies to localize 
the neurite-promoting site of laminin. Our findings with hu- 
man laminin are consistent with the results of Edgar et al. 
(1984) who reported that the neurite-promoting activity of 
mouse laminin is located close to the previously described 
heparin-binding domain at the end of  the long arm. However, 
since the truncated human laminin used in the present work 
does not bind to heparin but does promote neurite outgrowth, 
the neurite-promoting site appears to be different from the 
heparin-binding site. In addition, we show here that epitopes 
in the 400-kD component of laminin are present at the end 
of the long ann and suggest that the neurite-promoting site 
of laminin may be contained within its 400-kD component. 
Materials and Methods 
Isolation of  Laminin 
Human laminin was isolated in a truncated form as a set of large fragments 
from a mild pepsin digest of human placenta by affinity chrom~itb~raphy on 
monoclonal antibody Sepharose essentially as previously described (Wewer 
et al., 1983). The modifications used included the use of a lower concentra- 
tion of  pepsin (0.1 mg/rnl) for digestion and the use of  4 M KSCN for elution 
of laminin from the antibody column. The eluted material was dialyzed 
against 50 mM Tris-HCl, pH 8.2, and further purified by fast protein liquid 
chromatography  (Pharmacia  Fine  Chemicals,  Piscataway,  N J)  using  a 
Mono Q column (Pharmacia Fine Chemicals). The column was eluted using 
stepwise increases in NaCI concentration. A major protein peak with lami- 
nin immunoreactivity eluted at salt concentrations between 0.30 and 0.35 
M. This material was used in the present study.  Rat laminin was purified 
from rat yolk sac tumors (Engvall et al.,  1983). Mouse laminin was pur- 
chased from Bethesda Research Laboratories, Gaithersburg, MD. 
Analysis of  Heparin-binding Capacity 
of  Human Laminin Fragments 
3 mg of purified human laminin fragments in PBS, pH 7.2 (0.05 M phos- 
phate,  0.10 M  NaCl),  were  fractionated on a  1.5  ×  16-cm  column of 
heparin-Sepharose (Pharmacia Fine Chemicals) in PBS. The column was 
washed with PBS and eluted with 0.5 M NaCI in PBS. Laminin in the bound 
and unbound fractions was quantitated by absorbance at 280 nm and by reac- 
tivity with antibodies in ELISA (Engvall and Perlmann,  1972). 
Production of  Monoclonal Antibodies 
BALB/c mice (Bantin and Kingman, Fremont, CA) were immunized with 
human laminin fragments and the spleen cells from immunized mice were 
fused with cells of the myeloma line X63-Ag8.563,  using polyethylene gly- 
col according to techniques described previously (Ruoslahti et al.,  1982; 
Hessle and Engvall, 1984). Hybridomas were selected based on production 
of antibodies reacting with human laminin in ELISA (Engvall and Perl- 
mann, 1972), and on capacity to stain basement membranes in indirect im- 
munofluorescence of sections of placenta (Hessle et al.,  1984). Quantities 
of monoclonal antibodies were produced from cloned hybridomas by cell 
culture or by ascites production in syngeneic mice. The antibodies were 
purified by ammonium sulfate precipitation and protein A Sepharose (Phar- 
macia Fine Chemicals) affinity chromatography (Ey et al.,  1978). 
Indirect Immunofluorescence 
and Immunoprecipitation of  Laminin 
from Cultured Cells 
The procedures used were those described earlier (Hessle et al.,  1984; 
Hessle and Engvall, 1984). Frozen sections of placenta were air dried and 
fixed in  acetone.  The  sections were  incubated with hybridoma culture 
medium, washed, and incubated with fluorescein-labeled goat anti-mouse 
IgG diluted in PBS. Choriocarcinoma cells (JAR)  were labeled metaboli- 
cally with [35Slmethionine  (New England Nuclear, Boston, MA). Culture 
media were collected and made 0.5% Triton X-100, 0.5 M NaCl, and 0.2 
mM phenylmethylsulfonylfluoride. Monocional antibodies were adsorbed 
to protein A Sepharose beads, presaturated with rabbit anti-mouse IgG, and 
the antibody beads were then incubated with labeled culture media for 3 h 
at  room temperature.  The beads were washed with PBS-Tween 20  and 
bound protein was eluted by boiling in 4% SDS. The samples were analyzed 
by SDS PAGE. The gels were fixed and treated with Enlightning (New En- 
gland Nuclear) before drying and autoradiography. 
Ranking of  AJ~nities of  Monoclonal Antibodies 
The relative affinities of  the antibodies were ranked by diluting purified anti- 
bodies in microtiter wells coated with 100 I.tl of a solution of I lag/ml human 
laminin  and  by  detecting bound  antibodies  with  ELISA  (Engvall  and 
Perlmann, 1972). The lower the antibody concentration required to achieve 
50% of maximum binding, the higher the affinity of that antibody. There- 
fore, the concentration of antibody at half of its maximal absorbance in 
ELISA was taken as a relative measure of its affinity (Van Heyningen et al., 
1983). Assays were also done using microtiter wells pretreated with poly- 
ornithine (see below). 
Electron Microscopy of  Laminin-Antibody Complexes 
100 Ixg of laminin and 30 Isg of monoclonal antibody in 1 ml 0.1 M ammo- 
nium acetate, pH 7, were incubated at 37°C for 1 h. The solution was then 
sprayed on freshly cleaved mica discs and evaporated. The samples were 
processed for transmission electron microscopy after rotary shadowing as 
described (Engvall et al.,  1983;  1986). 
SDS PAGE and Immunoblotting 
SDS PAGE was performed either on gels of 5 % acrylamide using a discon- 
tinuous buffer system according to Laemmli (1970) or on 2-16% gradient 
gels (Pharmacia Fine Chemicals) at pH 7.2. After electrophoresis, proteins 
on the gels were electrophoretically transferred to nitrocellulose in a Tris- 
glycine buffer, pH 7.4,  at 20 V for 16 h.  Under these conditions, laminin 
polypeptides transferred completely and only  traces of myosin used as 
molecular mass marker remained in the gels. Polypeptides on the nitrocellu- 
lose were stained with Amido black or detected immunologically by ELISA 
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ture medium diluted 1:5 or rabbit antiserum diluted 1:1000 were incubated 
with the filters for 3  h.  Peroxidase-labeled antiimmunoglobulin (Bio-Rad 
Laboratories, Richmond, CA) was used to detect bound antibodies and di- 
amino benzidine (Litton Bionetics, Inc., Charleston, SC) was used for the 
color reaction. 
Neurite Promotion and Inhibition Assays 
The assays were performed using embryonic day 8 chick ciliary ganglion 
neuronal cultures essentially as previously described  (Manthorpe et al., 
1983; Davis et al., 1985a).  Briefly,  polyoruithine-coated tissue culture plas- 
tic wells (6-mm diameter, 96-well microplates) were treated with 5  p.g/ml 
of human laminin in PBS for 2-3 h at 37°C. The wells were washed once 
with  100 I.tl PBS containing 1% BSA and were either left untreated or in- 
cubated for 3-4 h  at 37°C with a  1:5 dilution of hybridoma supernate or 
1 I.tg/ml purified monoclonal antibodies. After washing two times 100 I.tl 
with PBS, the wells were incubated 2 h at 37°C with a 1:50 dilution of rabbit 
anti-mouse IgG or control (rabbit anti-human alpha-fetoprotein) antisera. 
The wells were again washed once with  100 I.tl PBS and  100  I.tl culture 
medium (Dulbecco's modified Eagle's basal medium supplemented with 
0.5%  BSA,  8  ×  10  -7 M  insulin, 3.3  x  10  -2  M  glucose, 2.6  x  10  -2 M 
NaHCO3, 2  x  10  -3 M  L-glutamine, 100 0.m/ml penicillin, and 100 trophic 
units/ml ciliary neuronotrophic factor) containing 1,000 neurons was added. 
Cultures were fixed after 3 h by the addition of 200 I~1 2% glutaraldehyde 
for 20 min, washed with water, and stained with 0.1% toluidine blue in wa- 
ter. About 150 neurons were observed microscopically for each culture con- 
dition. Neurons were recorded as neurite-bearing if they possessed at least 
50 lam of total neurite length (Davis et al.,  1985c). 
Results 
Characterization  of  Human Laminin Pepsin Fragment 
The material purified by fast protein liquid chromatography 
was characterized by SDS PAGE (Fig.  1).  Unreduced, the 
truncated human  laminin  ran as  a  major band of slightly 
smaller molecular size than unreduced mouse laminin used 
for comparison. After reduction, the mouse laminin showed 
the characteristic 200- and 400-kD polypeptides, while the 
human laminin showed several bands ranging from <100 kD 
to >400 kD. Because of the complex pattern of polypeptides 
in human laminin, it was not possible in this test to establish 
a relationship of any particular polypeptide in human lami- 
nin with either the 400- or the 200-kD polypeptide in mouse 
or rat laminin.  Furthermore, the presence of polypeptides 
larger than 400 kD in the reduced human laminin suggests 
that  laminin  in  normal  tissues,  such as  placenta,  may be 
cross-linked by other than only disulfide bonds. The isolated 
laminin fragments did not bind to heparin in affinity chroma- 
tography  under  the  conditions  used  (not  shown).  Most 
mouse and rat laminins bind to heparin under similar condi- 
tions (Sakashita et al.,  1980;  Engvall et al.,  1983). 
Isolation and Characterization  of  Monoclonal 
Antibodies to Human Laminin 
12 monoclonal antibodies that reacted with human laminin 
in ELISA were raised and characterized. All the antibodies 
were of the  IgG~ subclass  and  had  •  light chains.  When 
tested in ELISA against rat and mouse laminins, only anti- 
body 2E8 reacted with rat laminin, and, as expected, none 
of the antibodies reacted against mouse laminin. In indirect 
immunofluorescence, all the antibodies gave similar staining 
of both the trophoblast and the blood vessel basement mem- 
branes in human placenta and all the antibodies immuno- 
precipitated laminin from culture medium of JAR choriocar- 
cinoma cells (not shown). 
Figure 1.  SDS PAGE analysis of purified laminins on a 2-16% 
acrylamide gradient gel. Pepsin-fragmented human laminin after 
purification by antibody affinity chromatography and fast protein 
liquid chromatography (H) and  mouse  laminin  (M)  were  elec- 
trophoresed without (-) or with (+) reduction with 0.1 M 2-mer- 
captoethanol. The mobility on the same gel of proteins of known 
molecular masses are indicated. 
Effect of  Monoclonal Antibodies on Outgrowth of 
Neurites from Neurons Cultured on Human Laminin 
Neurons from chicken embryo ciliary ganglia show exten- 
sive outgrowth of neurites after 3 h of culture on a substrate 
of polyornithine and laminin (Davis et al., 1985c). Treatment 
of the polyornithine-human laminin substrate with culture 
medium from 9 out of 12 hybridomas had no apparent effect 
on neurite outgrowth (Fig. 2, Table I).  However, three hy- 
bridomas, 3E5, 4C7, and 4El0, appeared to produce antibod- 
ies capable of reducing the incidence of neurite-bearing cells 
and the length of individual neurites (Fig. 2). 
Amplification of  Monoclonal Antibody Blocking 
by Second Antibody 
To test possible mechanisms by which the three antibodies, 
3E5, 4C7,  and 4El0,  interfered with the neurite-promoting 
activity of laminin, we added a second antibody, an antibody 
to mouse tgG, to the neurite assay. The second antibody en- 
hanced  the blocking activity of antibodies  3E5,  4C7,  and 
4El0, suggesting that the blocking is the effect of steric hin- 
drance (Fig. 2, Table II). The second antibody had no effect 
on  the  neurite-promoting  activity  of laminin  when  used 
alone or in combination with other laminin antibodies. Rab- 
Engvall et al. Mapping of Domains in Laminin  Using Antibodies  2459 Figure 2.  Effect of monoclonal antibodies to human  laminin on extension of neurites  from neurons  cultured on human  laminin-coated 
substrata.  Neurons were plated in micro wells treated sequentially with polyornithine, human iaminin, hybridoma culture medium (mAb: 
2E8,  4G5, 4G12,  3E5, 4C7,  and 4El0),  and second antibody (rabbit anti-mouse IgG, RaMIgG,  or rabbit  anti-human alpha-fetoprotein 
as control).  The cells were fixed after 3  h  and  stained with toluidine blue.  Bar,  98  Ilm. 
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Neurite-promoting Activity of  Human Laminin 
Monoclonal antibody 
Percent of neurons withneuntes 
Experiment I*  Experiment II$ 
-  2nd Ab§  +  2nd Ab  -  2nd Ab  +  2rid Ab 
--  85  82  85  85 
2D9  86  81  NTII  NT 
2D10  85  74  NT  NT 
2E8  85  79  86  88 
2G4  82  79  NT  NT 
2G6  82  76  90  91 
3C7  81  77  NT  NT 
3E5  46  33  61  42 
4C7  82  51  66  39 
4C9  77  61  86  75 
4El0  16  I  44  4 
4G5  86  76  NT  NT 
4G12  79  70  89  75 
* Performed  using hybridoma culture  medium at a 
$ Performed  using purified antibody at  1 txg/ml. 
§ 2nd Ab, rabbit anti-mouse  IgG. 
II NT,  not tested. 
1:5 dilution• 
bit  antibodies  of irrelevant  specificities  had  no  effect on 
blocking or nonblocking monoclonal antibodies. 
Lack of Correlation between Neurite Blocking 
Activity and Antibody Affinity 
To exclude the possibility that the differences in the capaci- 
ties of the antibodies to block the neurite-promoting activity 
of laminin would be due to differences in antibody affinity 
or level of antibody binding to laminin, the antibodies were 
titrated in ELISA (Fig. 3). The highest level of binding of an- 
tibody to laminin was obtained with antibodies 2E8,  2G4, 
and 4El0 (Fig.  3, Table II). Since the laminin was isolated 
with the 4El0 antibody, the 4El0 binding level was arbitrarily 
set at 100%. Other antibodies reached plateau levels of 75- 
100%, suggesting that most, but not all, molecules of lami- 
Tt,'.'le II. Relative Affinities of  Monoclonal Antibodies to 
Human Laminin Measured as the Concentration of 
Antibody Required to Attain 50% of  Maximal Binding 
in ELISA 
Level of maximum 
Antibody  Relative affinity  binding* 
M×IO  ~  % 
2D9  1.3  75 
2D10  7.3  57 
2E8  1.8  115 
2G4  9.0  103 
2G6  5.7  89 
3C7  NM$  >61 
3E5  1.7  76 
4C7  0.63  25 
4C9  0.83  58 
4El0  1.7  100 
4G5  1.5  23 
4G12  2.1  86 
* Measured as percent of binding of antibody 4El0. 
$ NM,  not measurable. 
2.0 
•  •  -- O~  o'N, 
• 
•  °  ~ 
E 
O 
0.5  ~'D  --  ~~~--'---~  ~  ! 
,  b p  i  |  I  , 
1  0.1  0.01 
pg/ml 
Figure 3. Titration ofmonoclonal antibodies in ELISA. Purified an- 
tibodies were serially diluted in microtiter wells coated with lami- 
nin.  Bound antibodies  were detected using goat anti-mouse IgG 
coupled to alkaline phosphatase and the enzyme activity was mea- 
sured  using p-nitrophenyl  phosphate.  The antibodies  shown are 
2E8 (solid circle), 4El0 (solid triangle), 2G6 (solid square), 3E5 
(open circle), 4C7 (open triangle), and 4135 (open square). 
nin on the solid phase contained the epitopes for these anti- 
bodies. A  few antibodies, including 4C7 and 4G5 (Fig.  3), 
reached lower plateau levels, indicating that these antibodies 
reacted with epitopes not present in all the laminin fragments 
or with epitopes unavailable in some laminin molecules coated 
on polystyrene. Similar results were obtained with assay plates 
pretreated with polyornithine. 
The highest relative affinities were measured for antibod- 
ies 4C7 and 4C9 (Table II). 4C7 showed significant inhibition 
of neurite-promoting activity of laminin while 4C9 did not. 
Out of four antibodies with relative affinities between 1.4 and 
1.8  x  10  -8 M, two, 3E5 and 4El0, showed inhibition,  while 
the other two, 2E8 and 4G5, did not. Thus, there was no di- 
rect correlation between affinity and blocking capacity. 
Localization of  Epitopes in Laminin 
by Electron Microscopy 
To localize the  epitopes for the  monoclonal  antibodies  in 
laminin, complexes of human laminin and individual mono- 
clonal antibodies were prepared and examined by electron 
microscopy after rotary shadowing.  Fig. 4  shows a gallery 
of images of complexes prepared with different monoclonal 
antibodies. The blocking antibodies, 3E5, 4C7, and 4El0, all 
reacted with epitopes located near the end of the long arm. 
The 4El0 and 4C7 antibodies bound to the large globular do- 
main at the end of the long arm and the 3E5 antibody bound 
on the long arm of laminin just above this domain. The non- 
blocking antibodies, 2E8, 2G6, 4C9 (not shown), 4G5, and 
4G12, bound to sites elsewhere in the molecule (Fig. 4). For 
most antibodies tested, a high incidence of laminin-antibody 
interactions  was observed with the rotary shadowing tech- 
nique.  The majority of structures that could be identified as 
laminin had one antibody molecule bound per laminin mole- 
cule and the antibody was always bound in the same place. 
A  high incidence of laminin-antibody interaction was also 
seen with antibody 4C7, in contrast to the relatively low level 
Engvall et al.  Mapping  of Domains  in Laminin  Using Antibodies  2461 Figure 4. Electron microscopy after rotary shadowing of laminin-antibody  complexes prepared using antibodies 4C7, 4El0, 3E5, 2E8, 2G6, 
4G5, and 4G12. Arrows indicate antibodies bound to laminin. Bar, 68 lam. 
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For antibodies 4G5 and 2G6, a  lower incidence of laminin 
interaction was apparent, possibly because these antibodies 
reacted with sites on the short arms that were often missing 
from the truncated form of laminin.  When laminin was in- 
cubated  with  an  unrelated  antibody,  no  laminin-antibody 
complexes were found. 
These results suggested that the neurite-promoting site of 
laminin is located at the end of the long arm in the vicinity 
of the 4El0, 4C7,  and 3E5  epitopes. 
Reactivities of  Monoclonal Antibodies 
with Laminin Subunits 
Immunoblotting  was  used  to  define  the  reactivity  of the 
monoclonal antibodies with laminin subunits. 3 out of the 12 
antibodies, 2E8, 3E5, and 4El0, reacted with human laminin 
polypeptides transferred to nitrocellulose after SDS  PAGE 
(Fig. 5). All three reacted with multiple bands, reflecting the 
heterogeneous nature of the truncated human laminin and the 
presence of proteolytic cleavages at multiple  sites in each 
polypeptide component.  3E5  and 4El0 gave identical  pat- 
terns  of reactivity,  which  were different  from the  pattern 
given by 2E8.  The bands stained most intensely with anti- 
bodies 3E5 and 4El0 were two closely spaced bands at the 
level of the 400-kD component of rat laminin. Other strongly 
stained bands were located below the  level of the 200-kD 
component  of  rat  laminin.  The  band  that  stained  most 
strongly with antibody 2E8 had a mobility equal to the 200- 
kD component. When 2E8 was used in immunoblotting of 
rat laminin, only the 200-kD component of rat laminin was 
stained (Fig.  6).  Figure 6. Immunoblotting of rat laminin, electrophoresed on a 5 % 
acrylamide gel, using monoclonal antibody 2E8 and rabbit anti-rat 
(Rctrat) laminin.  The arrow indicates the top of the gel. 
Since we did not have sufficient amounts of intact human 
laminin available, a 2 % SDS,  1% mercaptoethanol extract of 
human amnion was used as a source of intact laminin,  this 
material was subjected to SDS PAGE, and the protein bands 
were transferred to nitrocellulose.  In this complex mixture 
of amnion proteins, the 4El0 antibody could be shown to re- 
act only with a band at 400 kD, whereas the 2E8 antibody 
reacted only with a band at 200 kD (Fig.  7). 
Figure 5.  Immunoblotting  of pepsin-fragmented  human  laminin 
using monoclonal antibodies.  Purified human laminin and a mix- 
ture of marker proteins were reduced and submitted to electropho- 
resis  in alternating  lanes of a 2-16%  gradient  gel,  transferred  to 
nitrocellulose,  and stained using monoclonal antibodies 2E8, 3E5, 
and 4El0 and peroxidase-labeled goat anti-mouse IgG. Mobilities 
of marker polypeptides are shown on the right and those of reduced 
mouse laminin are indicated by arrowheads on the left. The arrow 
indicates the top of the gel. 
Discussion 
We have produced a panel of monoclonal antibodies to hu- 
man laminin and used these to localize the neurite-promoting 
site.  3  out  of the  12  monoclonal  antibodies  characterized 
partially blocked the neurite-promoting activity of laminin. 
More'substantial blocking of this activity could be obtained 
by adding an antibody to mouse IgG. These three blocking 
antibodies reacted at or close to the globular domain at the 
end of the long arm of laminin. Monoclonal antibodies react- 
ing with domains in the laminin molecule distant from the 
end of the long arm had no effect on the neurite promotion 
either by themselves or in combination with antimouse IgG. 
We conclude that the three blocking antibodies react close 
to the neurite-promoting site of laminin.  The fact that anti- 
body affinity was not correlated with blocking activity and 
that an antibody to mouse IgG enhances the blocking by the 
EngvaU et al. Mapping of Domains in Laminin Using Antibodies  2463 Figure 7. Iinmunoblotting of proteins from amnion. Proteins were 
extracted using 2 % SDS and 1% mercaptoethanol, electrophoresed 
on a 2-16% gradient gel, transferred to nitrocellulose, and reacted 
with antibodies 4El0 and 2E8. Mobilities of marker polypeptides 
are shown on the right and those of reduced mouse laminin on the 
left (arrowheads). The arrow indicates the top of the gel. 
results from physical studies (Engel et al.,  1981; Ott et al., 
1982) and sequencing of  eDNA (Barlow et al., 1984), as well 
as  sequencing  of  proteolytic  fragments  (Paulson  et  al., 
1985),  have indicated that the COOH-terminal portions of 
the 200-kD polypeptides may form the rod-like portion of 
the long arm of laminin.  Monoclonal antibodies could be 
useful in  locating the  individual  polypeptides to different 
portions of the laminin cross. Three of our monoclonal anti- 
bodies reacted with conformation-independent determinants 
and could therefore  be used to identify which laminin subunit 
contained  the  epitope  by  immunoblotting.  One  antibody, 
2E8, reacted with a 200-kD polypeptide in both human and 
rat laminin. Its reactivity with the center of  the laminin cross 
in  electron microscopy thus establishes  the presence of a 
200-kD polypeptide in that area. The other two antibodies, 
3E5 and 4El0, bound to sites a  short distance apart in the 
laminin molecule, as evidenced by electron microscopy, and 
bound to the same peptides in human laminin fragments and 
with the 400-kD component in intact laminin. 3E5 and 4El0 
therefore appear to bind to relatively closely spaced epitopes 
within the 400-kD polypeptide of laminin.  Since both 3E5 
and 4El0 were capable of  blocking the neurite-promoting ac- 
tivity, the neurite-promoting site should be located close to 
the binding sites of these antibodies and would therefore be 
likely to reside within the 400-kD component. However, the 
assignment of the neurite-promoting site to a particular poly- 
peptide domain will require further experimentation. 
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primary antibody suggests that the mechanism of the block- 
ing is by steric hindrance, the double layer of antibodies be- 
ing more efficient in interfering with the neurite-promoting 
site than a single antibody. 
Our results on the location of the neurite-promoting do- 
main in laminin at the end of  the long arm are similar to those 
of Edgar et al.  (1984).  These workers showed that a large 
fragment from mouse laminin consisting of the globular do- 
main at the end of the long arm and a portion of the rod-like 
domain of the long arm contained neurite-promoting activ- 
ity. Furthermore, rabbit antibodies against only the globular 
end domain blocked the neurite-promoting activity of intact 
laminin. Antisera against other fragments of laminin had no 
effect. That the end of the long arm of mouse laminir;rbinds 
to heparin (Ott et al., 1982) in addition to promoting neurite 
outgrowth may be fortuitous. The two activities appear not 
to be mediated by the same site since the human laminin frag- 
ments that had full neurite-promoting activity did not bind 
to heparin. 
The molecular architecture of laminin is not yet known in 
detail. A 400-kD polypeptide has been proposed to make up 
all (Rao et al., 1982; Liotta et al., 1981)  or a major part (Palm 
et al., 1985) of the long arm of laminin and the 200-kD poly- 
peptides are thought to make up the short arms.  However, 
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